Recent Structural Insights into Cytochrome P450 Function.

Cytochrome P450 (P450) enzymes are important in the metabolism of drugs, steroids, fat-soluble vitamins, carcinogens, pesticides, and many other types of chemicals. Their catalytic activities are important issues in areas such as drug-drug interactions and endocrine function. During the past 30 years, structures of P450s have been very helpful in understanding function, particularly the mammalian P450 structures available in the past 15 years. We review recent activity in this area, focusing on the past 2 years (2014-2015). Structural work with microbial P450s includes studies related to the biosynthesis of natural products and the use of parasitic and fungal P450 structures as targets for drug discovery. Studies on mammalian P450s include the utilization of information about 'drug-metabolizing' P450s to improve drug development and also to understand the molecular bases of endocrine dysfunction.

[1]  M. Waterman,et al.  Crystal Structures of Trypanosoma brucei Sterol 14α-Demethylase and Implications for Selective Treatment of Human Infections*♦ , 2009, The Journal of Biological Chemistry.

[2]  Young-Tae Lee,et al.  P450cam visits an open conformation in the absence of substrate. , 2010, Biochemistry.

[3]  T. Poulos,et al.  Structure of cytochrome P450eryF involved in erythromycin biosynthesis , 1995, Nature Structural Biology.

[4]  F. Guengerich,et al.  Oxidation of benzo[a]pyrene by recombinant human cytochrome P450 enzymes. , 1995, Chemical research in toxicology.

[5]  T. Poulos,et al.  The crystal structure of chloroperoxidase: a heme peroxidase--cytochrome P450 functional hybrid. , 1995, Structure.

[6]  Jeffrey B. Endelman,et al.  Structure-Guided Recombination Creates an Artificial Family of Cytochromes P450 , 2006, PLoS biology.

[7]  T. Poulos,et al.  Structural and Mechanistic Insights into the Interaction of Cytochrome P4503A4 with Bromoergocryptine, a Type I Ligand* , 2011, The Journal of Biological Chemistry.

[8]  M. J. Coon,et al.  Role of hemoprotein P-450 in fatty acid omega-hydroxylation in a soluble enzyme system from liver microsomes. , 1968, The Journal of biological chemistry.

[9]  Shunji Takahashi,et al.  Structure-Function Analyses of Cytochrome P450revI Involved in Reveromycin A Biosynthesis and Evaluation of the Biological Activity of Its Substrate, Reveromycin T* , 2014, The Journal of Biological Chemistry.

[10]  T. Poulos,et al.  Structural Basis for Effector Control and Redox Partner Recognition in Cytochrome P450 , 2013, Science.

[11]  T. Poulos,et al.  Anion-Dependent Stimulation of CYP3A4 Monooxygenase. , 2015, Biochemistry.

[12]  Eric F. Johnson,et al.  Structural Diversity of Eukaryotic Membrane Cytochrome P450s* , 2013, The Journal of Biological Chemistry.

[13]  Jessica Lo,et al.  Novel aromatase inhibitors by structure-guided design. , 2012, Journal of medicinal chemistry.

[14]  M. Waterman,et al.  Role of Active Site Water Molecules and Substrate Hydroxyl Groups in Oxygen Activation by Cytochrome P450 158A2 , 2005, Journal of Biological Chemistry.

[15]  F. Guengerich,et al.  Common and uncommon cytochrome P450 reactions related to metabolism and chemical toxicity. , 2001, Chemical research in toxicology.

[16]  J. Pandit,et al.  Utilizing Structures of CYP2D6 and BACE1 Complexes To Reduce Risk of Drug–Drug Interactions with a Novel Series of Centrally Efficacious BACE1 Inhibitors , 2015, Journal of medicinal chemistry.

[17]  Kenneth A. Johnson,et al.  Role of Induced Fit in Enzyme Specificity: A Molecular Forward/Reverse Switch* , 2008, Journal of Biological Chemistry.

[18]  Frank E. Blaney,et al.  Crystal Structure of Human Cytochrome P450 2D6* , 2005, Journal of Biological Chemistry.

[19]  K. J. Ryan Conversion of androstenedione to estrone by placental microsomes. , 1958, Biochimica et biophysica acta.

[20]  Eric F. Johnson,et al.  Structural Characterization of the Complex between α-Naphthoflavone and Human Cytochrome P450 1B1* , 2010, The Journal of Biological Chemistry.

[21]  F. Guengerich,et al.  Conversion of 7-Dehydrocholesterol to 7-Ketocholesterol Is Catalyzed by Human Cytochrome P450 7A1 and Occurs by Direct Oxidation without an Epoxide Intermediate , 2011, The Journal of Biological Chemistry.

[22]  Conrad C. Huang,et al.  UCSF Chimera—A visualization system for exploratory research and analysis , 2004, J. Comput. Chem..

[23]  Bradley S Moore,et al.  Binding of Two Flaviolin Substrate Molecules, Oxidative Coupling, and Crystal Structure of Streptomyces coelicolor A3(2) Cytochrome P450 158A2* , 2005, Journal of Biological Chemistry.

[24]  Cataloging the Repertoire of Nature's Blowtorch, P450. , 2009, Chemistry & biology.

[25]  M. Waterman,et al.  The role of cytochrome b5 in the biosynthesis of androgens by human P450c17. , 1995, Archives of biochemistry and biophysics.

[26]  T. Poulos,et al.  Crystal structure of cytochrome P450 14α-sterol demethylase (CYP51) from Mycobacterium tuberculosis in complex with azole inhibitors , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[27]  L. Kang,et al.  Functional characterization of CYP107W1 from Streptomyces avermitilis and biosynthesis of macrolide oligomycin A. , 2015, Archives of biochemistry and biophysics.

[28]  Kang Lan Tee,et al.  Single-step fermentative production of the cholesterol-lowering drug pravastatin via reprogramming of Penicillium chrysogenum , 2015, Proceedings of the National Academy of Sciences.

[29]  W. Miller,et al.  Cytochrome b 5 Augments the 17,20-Lyase Activity of Human P450c17 without Direct Electron Transfer* , 1998, The Journal of Biological Chemistry.

[30]  T. Omura,et al.  A new cytochrome in liver microsomes. , 1962, The Journal of biological chemistry.

[31]  The crystal structure of chloroperoxidase: a heme peroxidase--cytochrome P450 functional hybrid. , 1995, Structure.

[32]  D. Lamb,et al.  Structure-Functional Characterization of Cytochrome P450 Sterol 14α-Demethylase (CYP51B) from Aspergillus fumigatus and Molecular Basis for the Development of Antifungal Drugs* , 2015, The Journal of Biological Chemistry.

[33]  J. Groves Models and Mechanisms of Cytochrome P450 Action , 2005 .

[34]  F. Mackenzie,et al.  Structural characterization of human cholesterol 7α-hydroxylase , 2014, Journal of Lipid Research.

[35]  Barry C. Jones,et al.  DRUG-DRUG INTERACTIONS FOR UDP-GLUCURONOSYLTRANSFERASE SUBSTRATES: A PHARMACOKINETIC EXPLANATION FOR TYPICALLY OBSERVED LOW EXPOSURE (AUCI/AUC) RATIOS , 2004, Drug Metabolism and Disposition.

[36]  S A van Acker,et al.  A predictive model for substrates of cytochrome P450-debrisoquine (2D6). , 1992, Chemical research in toxicology.

[37]  F. Guengerich,et al.  Substrate specificity of human liver cytochrome P-450 debrisoquine 4-hydroxylase probed using immunochemical inhibition and chemical modeling. , 1985, Cancer research.

[38]  Hee-won Park,et al.  Structural basis of human CYP51 inhibition by antifungal azoles. , 2010, Journal of molecular biology.

[39]  Eric F. Johnson,et al.  The Structure of Human Microsomal Cytochrome P450 3A4 Determined by X-ray Crystallography to 2.05-Å Resolution* , 2004, Journal of Biological Chemistry.

[40]  J. Tainer,et al.  Structure of nitric oxide synthase oxygenase dimer with pterin and substrate. , 1998, Science.

[41]  Jessica Lo,et al.  Structural basis for the functional roles of critical residues in human cytochrome p450 aromatase. , 2013, Biochemistry.

[42]  A. D. Rodrigues,et al.  Pharmacokinetic enhancement of inhibitors of the human immunodeficiency virus protease by coadministration with ritonavir , 1997, Antimicrobial agents and chemotherapy.

[43]  K. Korzekwa,et al.  Activation of CYP3A4: evidence for the simultaneous binding of two substrates in a cytochrome P450 active site. , 1994, Biochemistry.

[44]  D. Koshland,et al.  Comparison of experimental binding data and theoretical models in proteins containing subunits. , 1966, Biochemistry.

[45]  Slobodan Rendic,et al.  Survey of Human Oxidoreductases and Cytochrome P450 Enzymes Involved in the Metabolism of Xenobiotic and Natural Chemicals , 2014, Chemical research in toxicology.

[46]  C David Stout,et al.  Adaptations for the Oxidation of Polycyclic Aromatic Hydrocarbons Exhibited by the Structure of Human P450 1A2*♦ , 2007, Journal of Biological Chemistry.

[47]  Takashi Hayashi,et al.  Enzyme-substrate complex structures of CYP154C5 shed light on its mode of highly selective steroid hydroxylation. , 2014, Acta crystallographica. Section D, Biological crystallography.

[48]  Jose Cosme,et al.  Crystal structure of human cytochrome P450 2C9 with bound warfarin , 2003, Nature.

[49]  F. Guengerich Characterization of human cytochrome P450 enzymes , 1992, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[50]  H. Sugimoto,et al.  Crystal structure of H2O2-dependent cytochrome P450SPalpha with its bound fatty acid substrate: insight into the regioselective hydroxylation of fatty acids at the alpha position. , 2011, The Journal of biological chemistry.

[51]  M. Waterman,et al.  Structural and Kinetic Basis of Steroid 17 , 20-Lyase Activity in Teleost Fish Cytochrome P 450 17 A 1 and Its Absence in Cytochrome P 450 17 A 2 * , 2015 .

[52]  B. Brodie,et al.  The oxidation of drugs by liver microsomes: on the role of TPNH and oxygen. , 1957, The Journal of pharmacology and experimental therapeutics.

[53]  Bahman Zohuri Thermodynamics of Cycles , 2017 .

[54]  F. Guengerich,et al.  Human cytochrome P-450 enzymes. , 1992, Life sciences.

[55]  T. Poulos,et al.  Structure of a cytochrome P450-redox partner electron-transfer complex. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[56]  Eric F. Johnson,et al.  Determinants of Cytochrome P450 2C8 Substrate Binding , 2008, Journal of Biological Chemistry.

[57]  Jose Cosme,et al.  Crystal Structures of Human Cytochrome P450 3A4 Bound to Metyrapone and Progesterone , 2004, Science.

[58]  T. Poulos,et al.  Dissecting cytochrome P450 3A4-ligand interactions using ritonavir analogues. , 2013, Biochemistry.

[59]  T. Poulos,et al.  Structures of Cytochrome P450 Enzymes , 2015 .

[60]  T. Poulos,et al.  Preliminary crystallographic data on cytochrome P-450CAM. , 1982, The Journal of biological chemistry.

[61]  J. Idle,et al.  POLYMORPHIC HYDROXYLATION OF DEBRISOQUINE IN MAN , 1977, The Lancet.

[62]  Michael J. E. Sternberg,et al.  Evidence That Aspartic Acid 301 Is a Critical Substrate-Contact Residue in the Active Site of Cytochrome P450 2D6 (*) , 1995, The Journal of Biological Chemistry.

[63]  T. Yuen,et al.  Structure–phenotype correlations of human CYP21A2 mutations in congenital adrenal hyperplasia , 2013, Proceedings of the National Academy of Sciences.

[64]  J Deisenhofer,et al.  Crystal structure of hemoprotein domain of P450BM-3, a prototype for microsomal P450's. , 1993, Science.

[65]  J. Laurence,et al.  Human Cytochrome P450 17A1 Conformational Selection , 2014, The Journal of Biological Chemistry.

[66]  B. Griffin,et al.  Camphor binding by Pseudomonas putida cytochrome P-450. Kinetics and thermodynamics of the reaction. , 1972, Biochemistry.

[67]  J. Miller,et al.  The metabolism of 4-dimethylaminoazobenzene by rat liver homogenates. , 1948, The Journal of biological chemistry.

[68]  E. Scott,et al.  CYTOCHROME P450 17A1 STRUCTURES WITH PROSTATE CANCER DRUGS ABIRATERONE AND TOK-001 , 2011, Nature.

[69]  K. Battaile,et al.  Human Cytochrome P450 2E1 Structures with Fatty Acid Analogs Reveal a Previously Unobserved Binding Mode* , 2010, The Journal of Biological Chemistry.

[70]  D. Ghosh,et al.  Evidence for an Elevated Aspartate pKa in the Active Site of Human Aromatase* , 2014, The Journal of Biological Chemistry.

[71]  W. Pangborn,et al.  Structural basis for androgen specificity and oestrogen synthesis in human aromatase , 2009, Nature.

[72]  M. Waterman,et al.  Human Cytochrome P450 21A2, the Major Steroid 21-Hydroxylase , 2015, The Journal of Biological Chemistry.

[73]  M. Huang,et al.  Studies on the mechanism of activation of microsomal benzo[a]pyrene hydroxylation by flavonoids. , 1981, The Journal of biological chemistry.

[74]  G. Szklarz,et al.  Human Cytochrome P450 1A1 Structure and Utility in Understanding Drug and Xenobiotic Metabolism* , 2013, The Journal of Biological Chemistry.

[75]  David L. Williams,et al.  Correction: The Schistosoma mansoni Cytochrome P450 (CYP3050A1) Is Essential for Worm Survival and Egg Development , 2016, PLoS neglected tropical diseases.

[76]  F. Guengerich,et al.  Cooperativity in oxidations catalyzed by cytochrome P450 3A4. , 1997, Biochemistry.

[77]  Andrew W. Munro,et al.  Structure and Biochemical Properties of the Alkene Producing Cytochrome P450 OleTJE (CYP152L1) from the Jeotgalicoccus sp. 8456 Bacterium* , 2014, The Journal of Biological Chemistry.

[78]  Eric F. Johnson,et al.  Contributions of Ionic Interactions and Protein Dynamics to Cytochrome P450 2D6 (CYP2D6) Substrate and Inhibitor Binding* , 2015, The Journal of Biological Chemistry.

[79]  S. Imaoka,et al.  Role of phospholipids in reconstituted cytochrome P450 3A form and mechanism of their activation of catalytic activity. , 1992, Biochemistry.

[80]  Job L Grant,et al.  Decarboxylation of fatty acids to terminal alkenes by cytochrome P450 compound I. , 2015, Journal of the American Chemical Society.

[81]  J. Laurence,et al.  Cytochrome P450 17A1 Interactions with the FMN Domain of Its Reductase as Characterized by NMR* , 2015, The Journal of Biological Chemistry.

[82]  B C Finzel,et al.  The 2.6-A crystal structure of Pseudomonas putida cytochrome P-450. , 1985, The Journal of biological chemistry.

[83]  J. Peterson Camphor binding by Pseudomonas putida cytochrome P-450 , 1971 .

[84]  B C Finzel,et al.  Crystal structure of substrate-free Pseudomonas putida cytochrome P-450. , 1986, Biochemistry.

[85]  M. Cryle,et al.  Structure of OxyAtei: completing our picture of the glycopeptide antibiotic producing Cytochrome P450 cascade , 2016, FEBS letters.

[86]  L. Kang,et al.  Structural Analysis of the Streptomyces avermitilis CYP107W1-Oligomycin A Complex and Role of the Tryptophan 178 Residue , 2016, Molecules and cells.

[87]  Eric F. Johnson,et al.  The Structure of Human Cytochrome P450 2C9 Complexed with Flurbiprofen at 2.0-Å Resolution* , 2004, Journal of Biological Chemistry.

[88]  F Peter Guengerich,et al.  Three-dimensional Structure of Steroid 21-Hydroxylase (Cytochrome P450 21A2) with Two Substrates Reveals Locations of Disease-associated Variants* , 2012, The Journal of Biological Chemistry.

[89]  F. Mackenzie,et al.  Structural basis for pregnenolone biosynthesis by the mitochondrial monooxygenase system , 2011, Proceedings of the National Academy of Sciences.

[90]  E. Scott,et al.  Structures of Human Steroidogenic Cytochrome P450 17A1 with Substrates* , 2014, The Journal of Biological Chemistry.

[91]  H. Barnes,et al.  Expression and enzymatic activity of recombinant cytochrome P450 17 alpha-hydroxylase in Escherichia coli. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[92]  A. Bonvin,et al.  The HADDOCK web server for data-driven biomolecular docking , 2010, Nature Protocols.

[93]  S. Kandel,et al.  Analysis of Cytochrome P450 CYP119 Ligand-dependent Conformational Dynamics by Two-dimensional NMR and X-ray Crystallography* , 2015, The Journal of Biological Chemistry.

[94]  I. C. Gunsalus,et al.  A soluble cytochrome P-450 functional in methylene hydroxylation. , 1968, The Journal of biological chemistry.

[95]  J. Laurence,et al.  Substrate-modulated Cytochrome P450 17A1 and Cytochrome b5 Interactions Revealed by NMR* , 2013, The Journal of Biological Chemistry.

[96]  F. Guengerich,et al.  Expression of modified human cytochrome P450 3A4 in Escherichia coli and purification and reconstitution of the enzyme. , 1993, Archives of biochemistry and biophysics.

[97]  F. Guengerich,et al.  Kinetic Analysis of Oxidation of Coumarins by Human Cytochrome P450 2A6* , 2005, Journal of Biological Chemistry.

[98]  T. Poulos,et al.  Ritonavir analogues as a probe for deciphering the cytochrome P450 3A4 inhibitory mechanism. , 2014, Current topics in medicinal chemistry.

[99]  F Peter Guengerich,et al.  Complex reactions catalyzed by cytochrome P450 enzymes. , 2007, Biochimica et biophysica acta.

[100]  E. Scott,et al.  Structures of Human Cytochrome P-450 2E1 , 2008, Journal of Biological Chemistry.

[101]  Eric F. Johnson,et al.  Crystal Structure of Human Cytochrome P450 2D6 with Prinomastat Bound* , 2012, The Journal of Biological Chemistry.

[102]  T. Pochapsky,et al.  Detection of substrate-dependent conformational changes in the P450 fold by nuclear magnetic resonance , 2016, Scientific Reports.

[103]  F. Guengerich,et al.  Unusual Cytochrome P450 Enzymes and Reactions* , 2013, The Journal of Biological Chemistry.

[104]  W. Miller,et al.  P450 enzymes in steroid processing , 2015 .

[105]  J. Madura,et al.  Solution structural ensembles of substrate-free cytochrome P450(cam). , 2012, Biochemistry.

[106]  M. Waterman,et al.  Structural Basis for Rational Design of Inhibitors Targeting Trypanosoma cruzi Sterol 14α-Demethylase: Two Regions of the Enzyme Molecule Potentiate Its Inhibition , 2014, Journal of medicinal chemistry.

[107]  S. Guan,et al.  Mycobacterium tuberculosis CYP125A1, a steroid C27 monooxygenase that detoxifies intracellularly generated cholest‐4‐en‐3‐one , 2010, Molecular microbiology.

[108]  M. Egli,et al.  Research Resource: Correlating Human Cytochrome P450 21A2 Crystal Structure and Phenotypes of Mutations in Congenital Adrenal Hyperplasia. , 2015, Molecular endocrinology.

[109]  P. R. Montellano Substrate Oxidation by Cytochrome P450 Enzymes , 2015 .

[110]  M. Waterman,et al.  Structural and Kinetic Basis of Steroid 17α,20-Lyase Activity in Teleost Fish Cytochrome P450 17A1 and Its Absence in Cytochrome P450 17A2* , 2014, The Journal of Biological Chemistry.

[111]  Kenneth A. Johnson,et al.  Role of induced fit in limiting discrimination against AZT by HIV reverse transcriptase. , 2011, Biochemistry.

[112]  Dong-Sun Lee,et al.  Substrate Recognition and Molecular Mechanism of Fatty Acid Hydroxylation by Cytochrome P450 from Bacillus subtilis , 2003, The Journal of Biological Chemistry.

[113]  Gordon C K Roberts,et al.  Residues Glutamate 216 and Aspartate 301 Are Key Determinants of Substrate Specificity and Product Regioselectivity in Cytochrome P450 2D6* , 2003, The Journal of Biological Chemistry.

[114]  Robert L. Smith The Paton Prize Award. The discovery of the debrisoquine hydroxylation polymorphism: scientific and clinical impact and consequences. , 2001, Toxicology.

[115]  T. Shimada,et al.  Evidence for cytochrome P-450NF, the nifedipine oxidase, being the principal enzyme involved in the bioactivation of aflatoxins in human liver. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[116]  P. Ortiz de Montellano,et al.  Cholesterol Ester Oxidation by Mycobacterial Cytochrome P450* , 2014, The Journal of Biological Chemistry.

[117]  M. Nishiyama,et al.  Structure of the quinoline N‐hydroxylating cytochrome P450 RauA, an essential enzyme that confers antibiotic activity on aurachin alkaloids , 2014, FEBS letters.

[118]  T. Sjögren,et al.  Structural basis for ligand promiscuity in cytochrome P450 3A4 , 2006, Proceedings of the National Academy of Sciences.

[119]  R. Auchus,et al.  Catalytically Relevant Electrostatic Interactions of Cytochrome P450c17 (CYP17A1) and Cytochrome b5* , 2014, The Journal of Biological Chemistry.

[120]  L. Waskell,et al.  Kinetic and Structural Characterization of the Interaction between the FMN Binding Domain of Cytochrome P450 Reductase and Cytochrome c* , 2014, The Journal of Biological Chemistry.

[121]  D E McRee,et al.  Mammalian microsomal cytochrome P450 monooxygenase: structural adaptations for membrane binding and functional diversity. , 2000, Molecular cell.

[122]  Serge Léger,et al.  Diversity in the oxidation of substrates by cytochrome P450 2D6: lack of an obligatory role of aspartate 301-substrate electrostatic bonding. , 2002, Biochemistry.